Results
159
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
159 companies
Lobe Sciences
Market Cap: CA$11.9m
A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.
LOBE
CA$0.045
7D
-10.0%
1Y
125.0%
TRUBAR
Market Cap: CA$80.8m
Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.
TRBR
CA$0.76
7D
11.8%
1Y
24.6%
Cardiol Therapeutics
Market Cap: CA$128.1m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.54
7D
3.7%
1Y
-38.2%
Sharp Therapeutics
Market Cap: CA$30.0m
A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.
SHRX
CA$1.00
7D
0%
1Y
n/a
4Front Ventures
Market Cap: CA$4.6m
Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.
FFNT
CA$0.005
7D
0%
1Y
-96.4%
Microbix Biosystems
Market Cap: CA$31.4m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.23
7D
0%
1Y
-37.3%
Cytophage Technologies
Market Cap: CA$16.0m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.25
7D
0%
1Y
-12.3%
CanadaBis Capital
Market Cap: CA$5.5m
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
CANB
CA$0.04
7D
-11.1%
1Y
-33.3%
MindBio Therapeutics
Market Cap: CA$6.8m
Operates as a clinical stage drug development company in Australasia.
MBIO
CA$0.01
7D
100.0%
1Y
-66.7%
Adastra Holdings
Market Cap: CA$1.2m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.21
7D
-14.0%
1Y
-74.7%
Kane Biotech
Market Cap: CA$6.6m
A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.
KNE
CA$0.04
7D
-5.9%
1Y
-66.7%
Aptose Biosciences
Market Cap: CA$4.2m
A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.
APS
CA$1.65
7D
-2.4%
1Y
-89.4%
Appili Therapeutics
Market Cap: CA$1.8m
A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.
APLI
CA$0.015
7D
-25.0%
1Y
-50.0%
Onco-Innovations
Market Cap: CA$99.3m
A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.
ONCO
CA$1.95
7D
5.4%
1Y
n/a
EGF Theramed Health
Market Cap: CA$929.3k
Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.
TMED
CA$0.08
7D
0%
1Y
n/a
Quest PharmaTech
Market Cap: CA$5.9m
A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.
QPT
CA$0.035
7D
-12.5%
1Y
40.0%
HAVN Life Sciences
Market Cap: CA$859.4k
A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.
HAVN
n/a
7D
n/a
1Y
n/a
Ayr Wellness
Market Cap: CA$18.1m
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.
AYR.A
CA$0.15
7D
0%
1Y
-93.6%
Mountain Valley MD Holdings
Market Cap: CA$5.3m
A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.
MVMD
CA$0.02
7D
0%
1Y
-42.9%
Waverley Pharma
Market Cap: CA$810.0k
A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.
WAVE
CA$0.015
7D
0%
1Y
n/a
Revive Therapeutics
Market Cap: CA$8.6m
A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.
RVV
CA$0.02
7D
0%
1Y
100.0%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
BioVaxys Technology
Market Cap: CA$8.8m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.025
7D
-16.7%
1Y
-58.3%
FLUENT
Market Cap: US$38.0m
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.
FNT.U
US$0.06
7D
0%
1Y
-63.6%
HLS Therapeutics
Market Cap: CA$173.6m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$5.45
7D
1.7%
1Y
70.3%
FinCanna Capital
Market Cap: CA$5.0m
Does not have significant operations.
CALI.X
CA$0.005
7D
0%
1Y
0%
Blueberries Medical
Market Cap: CA$7.4m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
-25.0%
1Y
-25.0%
StageZero Life Sciences
Market Cap: CA$4.9m
A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.
SZLS
CA$0.04
7D
0%
1Y
-27.3%
Hemostemix
Market Cap: CA$19.0m
A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
HEM
CA$0.10
7D
-4.5%
1Y
40.0%
Aion Therapeutic
Market Cap: CA$2.5m
Engages in the health and wellness business in the United States.
AION
CA$0.005
7D
0%
1Y
-50.0%
Lophos Holdings
Market Cap: CA$858.6k
Through its subsidiaries, engages in the cultivation and research of peyote cactus.
MESC
CA$0.01
7D
0%
1Y
-75.0%
Lowell Farms
Market Cap: CA$272.2k
Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.
LOWL
CA$0.015
7D
0%
1Y
-57.1%
Helix BioPharma
Market Cap: CA$106.9m
Operates as an immune-oncology company in Canada.
HBP
CA$1.45
7D
6.6%
1Y
11.5%
Marvel Biosciences
Market Cap: CA$12.5m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.27
7D
-6.9%
1Y
125.0%
Herbal Dispatch
Market Cap: CA$4.9m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.06
7D
-29.4%
1Y
20.0%
Aequus Pharmaceuticals
Market Cap: CA$663.2k
Operates as a specialty pharmaceutical company in Canada.
AQS
CA$0.005
7D
0%
1Y
-80.0%